Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Opthea Limited

A Tale of Two Companies: SG&A Expenses Over Time

In the world of corporate finance, understanding operational costs is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Walgreens Boots Alliance, Inc. and Opthea Limited from 2014 to 2024. Walgreens, a giant in the pharmaceutical retail sector, consistently shows SG&A expenses in the tens of billions, peaking at approximately $28 billion in 2024. In contrast, Opthea, a smaller biotech firm, exhibits a more modest yet significant growth in SG&A expenses, increasing nearly 16-fold from 2014 to 2023. This stark contrast highlights the scale and operational strategies of these companies. While Walgreens' expenses reflect its expansive global operations, Opthea's rising costs may indicate strategic investments in research and development. This comparison underscores the diverse financial landscapes within the healthcare industry, offering insights into how companies allocate resources to maintain competitive edges.